| Product Name: | Glibenclamide Tablets IP |
| Brand Name: | Generics |
| Strength: | 2.5mg, 5mg |
| Dosage Form | Tablet (Un-coated) |
| Packing: | 30s, 90s, 100s |
| Route of Administration | Via Oral Route |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Regulatory Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antidiabetic |
| Indication: | Glibenclamide is used to lower the blood sugar level in patients with type 2 diabetes mellitus that is not controlled by diet and exercise alone. |
| Storage: | Protect form moisture at a temperature not exceeding 25˚C.Do not freeze. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
- Glibenclamide Tablets IP 2.5mg
- Glibenclamide Tablets IP 5mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
- Glibenclamide uncoated Tablets IP 2.5mg
Each tablet contains:
Glibenclamide IP ………….……2.5mg
Excipients…………………………q.s. - Glibenclamide Tablets IP 5mg
Each uncoated tablet contains:
Glibenclamide IP ……….….…5mg
Excipients………………………q.s.
THERAPEUTIC INDICATIONS:
Glibenclamide is used to lower the blood sugar level in patients with type 2 diabetes mellitus that is not controlled by diet and exercise alone.
CAUTION & WARNING:
CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.
STORAGE & DOSAGE:
Storage: Protect form moisture at a temperature not exceeding 25˚C.
Do not freeze.
Dosage: As directed by the Physician.
